Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02310763
Brief Title: A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular Dystrophy

First Submitted : November 4, 2014
First Submitted that Met QC Criteria : December 4, 2014
First Posted : December 8, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : January 3, 2019
Last Update Posted : January 4, 2019